Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
CLEC10A (C type lectin domain containing 10A) encodes a type II transmembrane C type lectin receptor predominantly expressed on myeloid derived immune cell populations, including antigen presenting cell subsets involved in immune recognition and tissue microenvironment surveillance. As a membrane anchored glycoprotein, CLEC10A is characterized by an N terminal cytoplasmic tail, a single pass transmembrane region, a stalk like neck domain, and an extracellular carbohydrate recognition domain that enables interaction with glycan containing binding partners. This structural architecture supports its role as a surface receptor capable of mediating cell contact dependent recognition events within immune cell niches.
At the plasma membrane, CLEC10A may assemble with other membrane resident or extracellular partner components to form transient receptor complexes that contribute to myeloid cell surface communication. Its expression and subcellular distribution can be influenced by immune microenvironment signals, which may affect receptor trafficking, recycling, and availability at the cell surface. Altered levels of functional CLEC10A may impact the stability of surface receptor assemblies and disturb myeloid cell membrane homeostasis, potentially affecting the ability of immune cells to respond appropriately to local environmental cues.
Sequence variations within the CLEC10A coding region may lead to structural changes that influence receptor folding, domain stability, or partner binding properties. While other C type lectin family members also recognize glycan related structures, they may not fully recapitulate the same receptor complex assembly patterns, subcellular trafficking behaviours, or myeloid cell surface functions associated with CLEC10A. This distinction makes CLEC10A a relevant research target for investigating C type lectin receptor biology, myeloid immune recognition, and cell surface receptor mediated membrane homeostasis.
In research settings, CLEC10A can be studied as a membrane protein target to explore receptor ligand interactions, glycan dependent recognition events, and immune cell surface regulation. Its preferential expression in myeloid compartments, combined with its characteristic extracellular lectin domain, supports its use in laboratory models focused on antigen presenting cell biology, immune receptor trafficking, and myeloid cell adaptive responses. Accordingly, CLEC10A related research reagents may assist in the comparative analysis of receptor structure, partner binding, and membrane associated immune signalling processes.
Fig. 1 Sequence alignment of CLEC10A and ASGR1. Conserved residues and key cytoplasmic motif are marked, showing homology within this receptor family.1
The biological functions of transmembrane CLEC10A lectin receptor protein are focused on sustained heteromeric partner-complex interaction and myeloid-cell membrane-homeostasis coordination:
Creative Biolabs offers purified CLEC10A membrane samples generated under unified preparation workflows, including full-length receptor constructs and isolated domain-truncated variants. Truncated domain fragments cannot support complete surface-partner-complex assembly behaviours, whereas full-length constructs suit research focused on receptor-partner interaction and plasma-membrane anchoring-related functional observation. All batches receive uniform quality screening. Function-oriented observation may only be performed using full-length samples under simulated plasma-membrane microenvironment setups. Consistent structural features are preserved across batches to support comparative laboratory analysis across separate test groups. Full-length CLEC10A samples retain intact partner-interaction-domain conformation after standardized purification, supporting reliable detection of weak and transient receptor-partner contacts for comparative functional analysis.
Not finding the Membrane potein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable CLEC10A expression cell research models with tunable target-expression levels, applicable to structural observation of type-II transmembrane C-type-lectin immune receptors and research into membrane-partner molecular interaction. Sample evaluation includes sustained target-receptor expression detection and preliminary partner-interaction observation, enabling side-by-side comparison of receptor-binding behaviours under differing target-protein abundances. These cell systems can pair with diverse laboratory analysis schemes to track changes in partner-assembly efficiency alongside shifting CLEC10A protein levels.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-CLEC10A recombinant antibodies are generated via standardized protein preparation workflows, compatible with routine laboratory detection techniques for plasma-membrane localization mapping and identification of receptor-partner molecular complexes. The antibody series can work alongside common laboratory detection reagents to realise multi-dimensional observation of target-receptor distribution within membrane-enriched sample materials.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for CLEC10A research:
CLEC10A might act as a type-II transmembrane C-type-lectin immune receptor and participate in heteromeric surface-complex assembly to modulate receptor-complex arrangement and myeloid-cell membrane homeostasis.
CLEC10A expression status could alter membrane-partner-complex assembly efficiency and local plasma-membrane-coupled molecular-interaction balance, serving as an important mediator of myeloid-cell-surface-homeostasis-associated biological processes.
No, CLEC10A-associated research reagents from Creative Biolabs are exclusively built for exploring C-type-lectin-receptor-dependent cell-surface regulatory mechanisms, and shall not be deployed for any clinical-oriented workflows. These preparations are optimized for basic laboratory investigation and do not satisfy performance benchmarks required for clinical implementation.
Offerings include full-length CLEC10A membrane protein, target-specific recombinant antibodies and tunable-expression cell research models, supporting research on myeloid-cell membrane homeostasis and receptor-mediated membrane-partner perception.
Laboratory observation schemes may include receptor-partner-interaction related tests to analyse molecular-binding associated behaviours under simulated plasma-membrane environments.